Epilepsy Action Australia / en Empowering Hope: ½πΊΜΣιΐΦ³Η Australia's Commitment to Childhood Epilepsy Research /solutions/magazine/detail/article/empowering-hope-ucb-australia-s-commitment-to-childhood-epilepsy-research <span>Empowering Hope: ½πΊΜΣιΐΦ³Η Australia's Commitment to Childhood Epilepsy Research</span> <div class="field field--name-field-newsroom-author-title field--type-string field--label-above field__items"> Xavier Hormaechea, Corporate Affairs </div> <span><span lang about="/user/8671" typeof="schema:Person" property="schema:name" datatype content="Nathalie.Vandenbruaene@ucb.com">Vandenbruaene …</span></span> <span><time datetime="2023-10-27T11:34:48+02:00" title="Friday 27 October 2023 - 11:34">Fri 27/10/2023 - 11:34</time> </span> <div class="field field--name-field-newsroom-author-image field--type-entity-reference field--label-above field__items"> <article class="media media--type-image media--view-mode-default"> <div class="field field--name-image field--type-image field--label-hidden field__items"> <img loading="lazy" src="/sites/default/files/styles/ucb_header_image/public/author_images/Xavier_Hormaechea_2.PNG.webp?itok=higveIUg" width="50" height="65" alt="Picture of atuhor Xavier Hormaechea" typeof="foaf:Image"> </div> </article> </div> <div class="field field--name-field-newsroom-content field--type-text-long field--label-above field__items"> <p><br> ½πΊΜΣιΐΦ³Η Australia has announced a research grant aimed at achieving early diagnosis and better outcomes for children living with severe genetic childhood epilepsy.</p> <p><strong>A Collaborative Approach to Transforming Lives</strong><br> October 27, 2023, marked a pivotal moment in the journey towards better understanding and managing childhood epilepsy. At an event titled 'Together for Severe Childhood Epilepsy,' ½πΊΜΣιΐΦ³Η Australia, in partnership with Epilepsy Action Australia, joined by Her Royal Highness Princess Astrid of Belgium, Representative of His Majesty the King, gathered with around 150 guests from the epilepsy and health community, families with children living with severe epilepsy, and representatives of the Belgian economic mission to Australia. This diverse gathering symbolized the collaborative spirit and optimism that inspires and drives ½πΊΜΣιΐΦ³Η's mission.<br> &nbsp;</p> <article data-quickedit-entity-id="media/45301" class="align-center media media--type-image media--view-mode-default"> <div class="field field--name-image field--type-image field--label-hidden field__items"> <img loading="lazy" src="/sites/default/files/styles/ucb_header_image/public/2023-10/½πΊΜΣιΐΦ³Η_Australia.png.webp?itok=WWOW8ZPR" width="650" height="433" typeof="foaf:Image"> </div> </article> <p class="text-align-center"><em>From the left to the right:&nbsp;HE Ambassador Goffin, Professor Ingrid Scheffer, Minister Willy Borsus, Xavier Hormaechea MD ½πΊΜΣιΐΦ³Η Belgium, HRH Princess Astrid, Selina Clifford Country Lead Australia, Dr Katherine Howell from Murdoch Institute, Carol Ireland from Epilepsy Action, Lachie Gillespie from the Wiggles</em></p> <p><br> ½πΊΜΣιΐΦ³Η Australia's latest research grant is the next step in a journey that began with the Gene-STEPS pilot studyβ€”an international multi-center effort to evaluate rapid genome sequencing in infantile epilepsy. The results of this study emphasize the importance of longitudinal follow-up in demonstrating the significance of rapid diagnosis. Such timely diagnoses are crucial in enhancing clinical outcomes, quality of life, and ultimately, economic well-being. The ripple effect of this research will not only inform advocacy and policy decisions but also change the lives of Australian children and their families.</p> <p>Dr. Katherine Howell, a consultant neurologist and recipient of ½πΊΜΣιΐΦ³Η's grant on behalf of the Murdoch Children's Research Institute (MCRI), expressed the importance of research in the quest to manage childhood epilepsies. She noted, β€œEpilepsy is not just one condition, there are many different forms, with many different causes. We’re privileged to be awarded this grant to continue the important research investigating the use and impact of rapid genome sequencing. The findings of this work will be critical for moving this technology out of the research sphere and into clinical practice, to improve outcomes for all Australian infants living with epilepsy.” Her dedication to investigating genome sequencing aspires for a brighter future for children living with epilepsy in Australia.</p> <p>Ms Carol Ireland, CEO, Epilepsy Action Australia said: β€œI’ve met many families who have children with challenging epilepsy, including those with drug resistant epilepsy and some of the more devastating syndromes. Continuing research for early diagnosis and effective treatment to target seizure control is essential to give these children the best possible start and optimal psychosocial and health outcomes for life. We thank researchers like Dr Katherine Howell as well as ½πΊΜΣιΐΦ³Η who are continuing to support and foster better understanding into these debilitating chronic neurological conditions.”</p> <p>At the event, Lachy, the Purple Wiggle, an ambassador for Epilepsy Action Australia shared stories from families impacted by severe genetic epilepsy.</p> <p>Approximately 1 in 200 children in Australia battles epilepsy, this condition characterized by recurrent, unprovoked seizures. These seizures vary in severity, with some children facing developmental impairments, drug-resistant seizures, and a high risk of mortality. These severe epilepsies come with psychosocial implications for the children and substantial economic costs for their families and the healthcare system.</p> <p>In a world where collaboration, compassion, and cutting-edge research converge, ½πΊΜΣιΐΦ³Η Australia's commitment to childhood epilepsy remains strong. Together, we are driving change, embodying the values that truly matter in life. &nbsp;At ½πΊΜΣιΐΦ³Η we remain inspired by patients and driven by science, always.</p> <article data-quickedit-entity-id="media/45389" class="align-center media media--type-video media--view-mode-embedded"> <div class="field field--name-field-media-video-embed-field field--type-video-embed-field field--label-hidden field__items"> <div class="video-embed-field-provider-vimeo video-embed-field-responsive-video"><iframe width="854" height="480" frameborder="0" allowfullscreen="allowfullscreen" src="https://player.vimeo.com/video/889138458?autoplay=0"></iframe> </div> </div> </article> </div> <div class="field field--name-field-newsroom-category field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1909" hreflang="en">solutions</a> </div> <div class="field field--name-field-newsroom-tags field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/5437" hreflang="en"> epilepsy</a> <a href="/taxonomy/term/10449" hreflang="en">½πΊΜΣιΐΦ³Η Australia</a> <a href="/taxonomy/term/10450" hreflang="en">Research grant</a> <a href="/taxonomy/term/10451" hreflang="en">Epilepsy Action Australia</a> </div> <div> <div class="comments-wrapper"> <div class="comment-area"> <h2 class="red">Leave a Comment</h2> <drupal-render-placeholder callback="comment.lazy_builders:renderForm" arguments="0=node&amp;1=14895&amp;2=field_newsroom_askexpert&amp;3=ask_expert" token="drM_xn6Z29o-FSNA6xOvaq2DwM1M-VgjrQrSt89JG80"></drupal-render-placeholder> <span class="toggle-form js-toggle-form"></span> </div> </div> </div> <span class="a2a_kit a2a_kit_size_16 addtoany_list" data-a2a-url="/solutions/magazine/detail/article/empowering-hope-ucb-australia-s-commitment-to-childhood-epilepsy-research" data-a2a-title="Empowering Hope: ½πΊΜΣιΐΦ³Η Australia's Commitment to Childhood Epilepsy Research"><a class="a2a_dd addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ucb.com%2Fsolutions%2Fmagazine%2Fdetail%2Farticle%2Fempowering-hope-ucb-australia-s-commitment-to-childhood-epilepsy-research&amp;title=Empowering%20Hope%3A%20½πΊΜΣιΐΦ³Η%20Australia%27s%20Commitment%20to%20Childhood%20Epilepsy%20Research"></a><a class="a2a_button a2a_button_facebook"><img src="/themes/custom/ucb_premier/images/a2a/facebook-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_linkedin"><img src="/themes/custom/ucb_premier/images/a2a/linkedin-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_twitter"><img src="/themes/custom/ucb_premier/images/a2a/twitter-icon.svg" width="16" height="16" border="0" alt="twitter"></a></span> <div class="field field--name-field-like field--type-likes-dislikes field--label-above field__items"> <div class="like_dislike"> <div class="like"> <a rel="nofollow" class="use-ajax" href="/like-dislike/like/eyJlbnRpdHlfdHlwZSI6Im5vZGUiLCJlbnRpdHlfaWQiOiIxNDg5NSIsImZpZWxkX25hbWUiOiJmaWVsZF9saWtlIiwibGlrZXMiOiI0MzUiLCJkaXNsaWtlcyI6Ii01OSJ9"></a> <span class="like-14895"> 435 Likes </span> </div> </div> <div id="like_dislike_status"></div> </div> Fri, 27 Oct 2023 09:34:48 +0000 Vandenbruaene Nathalie 14895 at